From Dr. Bredesen
Chief Science Officer
February 17, 2025•From Dr. Bredesen, News
In Apple Cider Vinegar, Dr. Bredesen discusses the new Netflix series of the same name. This series raises questions about alternative therapies in the era of social networking. However, it also raises the tacit question of why so much trust has been lost in mainstream medicine, pushing so many to seek, and often find, success in areas such as functional medicine and integrative medicine. Read More »
January 16, 2025•From Dr. Bredesen, News
The Illhehad and the Odyssey: Remarkable Progress from Biomarker Testing
The ability to peer into the brain without expensive, harmful, and invasive procedures has long been a holy grail in neuroscience. Now, thanks to the emergence of novel blood-based biomarkers found in BrainScan, this is finally becoming a reality. In Dr. Bredesen's blog, The Illhehad and the Odyssey: Remarkable Progress from Biomarker Testing, he explores the lessons learned from this groundbreaking innovation. Read More »
December 19, 2024•From Dr. Bredesen, News
In Dr. Bredesen’s blog, 2025 May Be the Year, he describes a recent patient who ran into a tragic, and sadly all-too-common problem with healthcare. Recent events have highlighted the dire need for a less antiquated system of healthcare and public health. When it comes to healthcare costs, the US is the world leader, but when it comes to healthcare results, the US trails behind all comparable countries, from the UK to Australia to Canada to France to Germany to Switzerland to Japan, South Korea, and on and on. Yet despite these sobering statistics, recent disruptive events offer hope that change may finally be at hand. Read More »
November 19, 2024•From Dr. Bredesen, News
How the LA Times Got it Backwards
The blog, How the LA Times Got It Backwards, explains why the recent op-ed encouraging all of us to avoid testing for Alzheimer’s (!) is misinformed, misguided, and could lead to dementia in many people needlessly. Early testing for chronic diseases such as diabetes, hypertension, cardiovascular disease, cervical cancer, and colorectal cancer has been our most potent weapon against these common and high-mortality diseases. As he points out, there are two new advances that, if we all availed ourselves of these, could make Alzheimer’s dementia a very rare condition. Read More »
October 22, 2024•From Dr. Bredesen, News
The Large and Growing Armamentarium
In The Large and Growing Armamentarium, Dr. Bredesen describes some of the many new methods we have to diagnose and track brain and overall health that better allow us to utilize new therapeutic methods that have become available and are contributing to improved outcomes in those with cognitive decline or risk for decline. For those who start early, with prevention or early intervention, the dementia of Alzheimer’s is now, for the first time, optional. Read More »
September 23, 2024•From Dr. Bredesen, News
In, A Holy Grail for ApoE4?, Dr. Bredesen describes a remarkable new drug candidate that appears to reduce the genetic risk of ApoE4. This potentially game-changing drug was born out of decades of work that began in Dr. Bredesen’s lab at the Buck Institute. Once it is eligible, he plans to make a strong case for compassionate use, given that no other medications have proven capable of sustainably improving cognition for this subgroup. Read More »
August 19, 2024•From Dr. Bredesen, News
Why Alzheimer’s Is Now Optional
In Dr. Bredesen's blog, Why Alzheimer's is Now Optional, he discusses how a direct-to-consumer blood test, that can track your Alzheimer's status and progress, has replaced expensive, high-radiation PET scans, and painful spinal taps to empower patients to take control over their cognitive destiny. A simple blood test has entirely changed the Alzheimer's landscape and puts the power directly in the hands of consumers. Read More »
July 24, 2024•From Dr. Bredesen, News
In Dr. Bredesen’s blog, he describes a study in which autism was reversed in twins, a result that some called a miracle. He discusses the implications for the treatment of other developmental disorders, and for the practice of 21st-century medicine. Read More »